Experimental Testing of the New Biomedical Substance of Pig Kidneys for the Treatment of Nephrolithiasis

The aim of our study was to test anti-lithogenic activity of the new biomedical substance from pig kidneys (PK-BMS) on the experimentally induced nephrolithiasis. Materials and Methods: The experiments were performed with 30 male Wistar outbred rats weighting 220g-280g. The experimental animals we...

Full description

Bibliographic Details
Main Authors: Aleksandr Yu. Zharikov, Igor P. Saldan, Valery I. Kiselev, Ganna V. Pavlyashik
Format: Article
Language:English
Published: International Medical Research and Development Corporation 2017-03-01
Series:International Journal of Biomedicine
Subjects:
Online Access:http://ijbm.org/articles/IJBM_7(1)_OA4.pdf
_version_ 1818807974356844544
author Aleksandr Yu. Zharikov
Igor P. Saldan
Valery I. Kiselev
Ganna V. Pavlyashik
author_facet Aleksandr Yu. Zharikov
Igor P. Saldan
Valery I. Kiselev
Ganna V. Pavlyashik
author_sort Aleksandr Yu. Zharikov
collection DOAJ
description The aim of our study was to test anti-lithogenic activity of the new biomedical substance from pig kidneys (PK-BMS) on the experimentally induced nephrolithiasis. Materials and Methods: The experiments were performed with 30 male Wistar outbred rats weighting 220g-280g. The experimental animals were divided into two groups. In the disease-control group (DCG), the animals received a 1% solution of EG for 6 weeks. The rats in therapy group (TG), beginning from the fourth week, in addition to the daily EG intake, received PK-BMS in the amount of 1.0 per rat. The production of this substance was carried out at Altaivitaminy ZAO (Biysk, Altai Krai, Russia) by the method of cool dehumidification. In daily urine, we determined the concentration of oxalate, phosphate and calcium ions, creatinine excretion every 3 or 4 days in both groups; the activity of LDH, GGT, and NAG was measured every 7 days in the injured kidney epithelium. For the study of free-radical oxidation activity and for morphological examination of animal kidneys, after 6 weeks of the experiment, 5 rats from each group were euthanized. The occurrence of calcium compounds was determined by von Kossa’s staining method. Results: After a 6-week EG intake, we found the typical biochemical and morphological symptoms of experimental nephrolithiasis in rats of DCG: urine supersaturation with oxalate ions, significant increase in the activity of marker enzymes, activation of free-radical oxidation in the kidneys, and formation of calcium deposits in the kidneys. In TG, the new PK-BMS intake resulted in a significant alleviation of the experimental nephrolithiasi: significant decrease in the level of oxalate ions and activity of marker enzymes, reduction of free-radical oxidation in the kidneys, decrease in the number and size of calcium deposits in the area of renal papillae. Conclusion: It was established that during the experimental nephrolithiasis, a three-week intake of the new PK-BMS is accompanied by a significant anti-lithogenic effect.
first_indexed 2024-12-18T19:34:11Z
format Article
id doaj.art-e8ddbec153d342f3a99a0f242382d094
institution Directory Open Access Journal
issn 2158-0510
2158-0529
language English
last_indexed 2024-12-18T19:34:11Z
publishDate 2017-03-01
publisher International Medical Research and Development Corporation
record_format Article
series International Journal of Biomedicine
spelling doaj.art-e8ddbec153d342f3a99a0f242382d0942022-12-21T20:55:39ZengInternational Medical Research and Development CorporationInternational Journal of Biomedicine2158-05102158-05292017-03-0171414510.21103/Article7(1)_OA4Experimental Testing of the New Biomedical Substance of Pig Kidneys for the Treatment of NephrolithiasisAleksandr Yu. Zharikov0Igor P. Saldan1Valery I. Kiselev2Ganna V. Pavlyashik3Altai State Medical UniversityAltai State Medical UniversityAltai State Medical UniversityAltai State Medical UniversityThe aim of our study was to test anti-lithogenic activity of the new biomedical substance from pig kidneys (PK-BMS) on the experimentally induced nephrolithiasis. Materials and Methods: The experiments were performed with 30 male Wistar outbred rats weighting 220g-280g. The experimental animals were divided into two groups. In the disease-control group (DCG), the animals received a 1% solution of EG for 6 weeks. The rats in therapy group (TG), beginning from the fourth week, in addition to the daily EG intake, received PK-BMS in the amount of 1.0 per rat. The production of this substance was carried out at Altaivitaminy ZAO (Biysk, Altai Krai, Russia) by the method of cool dehumidification. In daily urine, we determined the concentration of oxalate, phosphate and calcium ions, creatinine excretion every 3 or 4 days in both groups; the activity of LDH, GGT, and NAG was measured every 7 days in the injured kidney epithelium. For the study of free-radical oxidation activity and for morphological examination of animal kidneys, after 6 weeks of the experiment, 5 rats from each group were euthanized. The occurrence of calcium compounds was determined by von Kossa’s staining method. Results: After a 6-week EG intake, we found the typical biochemical and morphological symptoms of experimental nephrolithiasis in rats of DCG: urine supersaturation with oxalate ions, significant increase in the activity of marker enzymes, activation of free-radical oxidation in the kidneys, and formation of calcium deposits in the kidneys. In TG, the new PK-BMS intake resulted in a significant alleviation of the experimental nephrolithiasi: significant decrease in the level of oxalate ions and activity of marker enzymes, reduction of free-radical oxidation in the kidneys, decrease in the number and size of calcium deposits in the area of renal papillae. Conclusion: It was established that during the experimental nephrolithiasis, a three-week intake of the new PK-BMS is accompanied by a significant anti-lithogenic effect.http://ijbm.org/articles/IJBM_7(1)_OA4.pdfexperimental nephrolithiasisanti-lithogenic activitybiomedical substancepig kidneys
spellingShingle Aleksandr Yu. Zharikov
Igor P. Saldan
Valery I. Kiselev
Ganna V. Pavlyashik
Experimental Testing of the New Biomedical Substance of Pig Kidneys for the Treatment of Nephrolithiasis
International Journal of Biomedicine
experimental nephrolithiasis
anti-lithogenic activity
biomedical substance
pig kidneys
title Experimental Testing of the New Biomedical Substance of Pig Kidneys for the Treatment of Nephrolithiasis
title_full Experimental Testing of the New Biomedical Substance of Pig Kidneys for the Treatment of Nephrolithiasis
title_fullStr Experimental Testing of the New Biomedical Substance of Pig Kidneys for the Treatment of Nephrolithiasis
title_full_unstemmed Experimental Testing of the New Biomedical Substance of Pig Kidneys for the Treatment of Nephrolithiasis
title_short Experimental Testing of the New Biomedical Substance of Pig Kidneys for the Treatment of Nephrolithiasis
title_sort experimental testing of the new biomedical substance of pig kidneys for the treatment of nephrolithiasis
topic experimental nephrolithiasis
anti-lithogenic activity
biomedical substance
pig kidneys
url http://ijbm.org/articles/IJBM_7(1)_OA4.pdf
work_keys_str_mv AT aleksandryuzharikov experimentaltestingofthenewbiomedicalsubstanceofpigkidneysforthetreatmentofnephrolithiasis
AT igorpsaldan experimentaltestingofthenewbiomedicalsubstanceofpigkidneysforthetreatmentofnephrolithiasis
AT valeryikiselev experimentaltestingofthenewbiomedicalsubstanceofpigkidneysforthetreatmentofnephrolithiasis
AT gannavpavlyashik experimentaltestingofthenewbiomedicalsubstanceofpigkidneysforthetreatmentofnephrolithiasis